Hyperthermia in combined treatment of cancer (Q34766163)

4 August 2017

1 reference

title

Hyperthermia in combined treatment of cancer (English)

1 reference

4 August 2017

P Wust

1

1 reference

4 August 2017

B Hildebrandt

2

1 reference

4 August 2017

G Sreenivasa

3

1 reference

4 August 2017

B Rau

4

1 reference

4 August 2017

J Gellermann

5

1 reference

4 August 2017

H Riess

6

1 reference

4 August 2017

R Felix

7

1 reference

4 August 2017

P M Schlag

8

1 reference

4 August 2017

publication date

1 August 2002

1 reference

Lancet Oncology Commission

4 August 2017

published in

1 reference

4 August 2017

volume

3

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

487-497

1 reference

Arrhenius relationships from the molecule and cell to the clinic

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Will hyperthermia conquer the elusive hypoxic cell? Implications of heat effects on tumor and normal-tissue microcirculation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

For the clinical application of thermochemotherapy given at mild temperatures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Effect of heat on induction and repair of DNA strand breaks in X-irradiated CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Nuclear matrix as a target for hyperthermic killing of cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Hyperthermia for treatment of rectal cancer: evaluation for induction of multidrug resistance gene (mdr1) expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Tumour oxygenation is increased by hyperthermia at mild temperatures

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Cytokine induction by 41.8 degrees C whole body hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Quality assurance guidelines for ESHO protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Dose uniformity in MECS interstitial hyperthermia: the impact of longitudinal control in model anatomies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Clinical evaluation and verification of the hyperthermia treatment planning system hyperplan.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Electromagnetic phased arrays for regional hyperthermia: optimal frequency and antenna arrangement

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Antenna arrays in the SIGMA-eye applicator: interactions and transforming networks

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Magnetic Resonance Thermometry During Hyperthermia for Human High-Grade Sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

[MRI-controlled regional hyperthermia]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Three‐dimensional monitoring of small temperature changes for therapeutic hyperthermia using MR

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Modeling and observation of temperature changes in vivo using MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Whole body hyperthermia: a secure procedure for patients with various malignancies?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Whole-body hyperthermia with water-filtered infrared radiation: technical-physical aspects and clinical experiences

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Feasibility and analysis of thermal parameters for the whole-body-hyperthermia system IRATHERM-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Head and neck cancers: results of thermoradiotherapy versus radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Thermoradiotherapy of patients with locally advanced carcinoma of the rectum

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

A prospective randomized study of regional extremity perfusion in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the Wor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Combined hyperthermia and irradiation in the treatment of superficial tumors: results of a prospective randomized trial of hyperthermia fractionation (1/wk vs 2/wk)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Cumulative minutes with T90 greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

[Phase II study on preoperative radio-chemo-thermotherapy in locally advanced rectal carcinoma].

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Hyperthermia in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Regional hyperthermia for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2802%2900818-5

7 January 2021

10.1016/S1470-2045(02)00818-5

Identifiers

DOI

1 reference

4 August 2017

1 reference